Baxion
ScreeningTagsAlerts

Aktis Oncology, Inc.

AKTS·NASDAQ·$18.09Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/2610-QQ1 ended 03/31/2605/11/2610-KFY 202503/30/26

Disclosures

8-KCurrent report08/13/268-KCurrent report05/11/268-KCurrent report04/16/268-KCurrent report03/30/268-KCurrent report01/12/26

Prospectuses and Registrations

S-8Registration of securities for employees01/12/26424B4Prospectus01/09/26S-1/ARegistration statement (amended)01/07/26S-1/ARegistration statement (amended)01/05/26S-1Registration statement (IPO)12/19/25

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/24/26144Proposed sale of securities09/23/26Form 4Insider transaction07/21/26144Proposed sale of securities07/20/26Form 4Insider transaction07/20/26

Other

CERTCEO/CFO certification01/08/26EFFECTRequest for effectiveness01/08/268-A12B8-A12B01/07/26DRS/ADRS/A11/14/25DRS/ADRS/A05/22/25

Latest Filings

10-QQ2 ended 06/30/2608/13/268-KCurrent report08/13/2610-QQ1 ended 03/31/2605/11/268-KCurrent report05/11/268-KCurrent report04/16/26

Ownership

Form 4Insider transaction09/24/26144Proposed sale of securities09/23/26Form 4Insider transaction07/21/26144Proposed sale of securities07/20/26Form 4Insider transaction07/20/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact